SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4626sciencedaily.com >> New Explanation for Heart-Healthy Benefits of Chocolabob zagorin-2/9/2011
4625PCSK9: competing programs from Amgen, Pfizer, and Regeneron, all using antibodituck-2/8/2011
4624The royalties are de minimis, as far as I can tell.DewDiligence_on_SI-2/7/2011
4623isis has royalties from abbott on ibis.. more Plex-ID news finance.yahoo.combob zagorin-2/7/2011
4622finance.yahoo.com WASHINGTON, Feb. 7, 2011 /PRNewswire/ -- Today, at the Amerbob zagorin-2/7/2011
4621Regulus IPO? xconomy.combob zagorin-2/7/2011
4620But the tissue concentration of Mipomersen does not peak until about 26 weeks. tuck-2/6/2011
4619fwiw repost from iv board. good inf. imo... P-2 WHOOPS. Sorry Posters & Reabob zagorin-2/5/2011
4618i think the stock is selling off on a combination of two things: 1. the fda asbob zagorin-1/21/2011
4617I hope they wait just a little longer to raise the offer as I will buy a few morMr. Sunshine-1/20/2011
4616no problem. if i'd have as well with all my other stocks as i have with isisbob zagorin-1/18/2011
4615Bob, thanks for keeping this thread going. ISIS is one of the few Biotechs I owMr. Sunshine-1/18/2011
4614Collins and Stewart think that GENZ is making progress in moving Mipo forward: Gbob zagorin-1/14/2011
4613copied from IV board but looks good to me. the fda sign off not requiring outcombob zagorin-1/12/2011
4612Isis CEO expects Sanofi to acquire Genzyme By Deena Beasley SAN FRANCISCO | Tubob zagorin-1/12/2011
4611good notes on isis cc (from another poster.. FDA-Mipomersen Conference Call Tobob zagorin-1/11/2011
4610Huh! STAT3 again? When Lilly is either in super slo-mo or doing nothing for sotuck-1/6/2011
4609Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline ISIS-FGFR4Rx to bob zagorin-1/6/2011
4608Isis Initiates Broad Phase 2 Program of ISIS-EIF4ERx in Cancer Initial Studies bob zagorin-1/4/2011
4607Isis initiates Phase 1 trial for APO CIIIRx to treat Hypertriglyceridemia ir.ibob zagorin-12/22/2010
4606Isis (ISIS): Deep Pipeline, Long Term Value By: TheStockAdvisors.com Thursday,bob zagorin-12/16/2010
4605Isis and Xenon Collaborate to Develop Antisense Drugs Against Hemojuvelin and Hebob zagorin-11/16/2010
4604zacks report on isis q.. Zacks Equity Research, On Monday November 15, 2010, 3:bob zagorin-11/15/2010
4603Glaxo bets on gene therapy in rare diseases drive Mon, 18 Oct 2010 15:52:00 GMTbob zagorin-10/18/2010
4602October 4, 2010 Sanofi-Aventis launches Genzyme takeover battle By GREG KELLER Abob zagorin-10/4/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News